Key result
Routine depression screening and multidisciplinary care are recommended for cardiovascular disease patients.
Why the study?
The burden of depression in cardiovascular disease is under-recognized, and screening and management strategies have been poorly implemented despite worsening clinical outcomes.
Do standardized screening and management of depression improve mental health and cardiovascular outcomes in patients with cardiovascular disease?
Do standardized screening and management of depression improve mental health and cardiovascular outcomes in patients with cardiovascular disease?
Routine screening for depression using validated tools and a multidisciplinary management approach is recommended to address the high burden and adverse prognostic impact of depression in patients with cardiovascular disease.
Answers are grounded in this paper and cite their sources.
Supports depression screening in CVD; leaves open need for large RCTs confirming CV outcome benefits.
Depression is a common problem in patients with cardiovascular disease (CVD) and is associated with increased mortality, excess disability, healthcare expenditures, and reduced quality of life. Depression is present in 1 in 5 patients with coronary artery disease, peripheral artery disease, and heart failure. Depression complicates the optimal management of CVD by worsening cardiovascular risk factors and decreasing adherence to healthy lifestyles and evidence-based medical therapies. As such, standardized screening pathways for depression in patients with CVD offer the potential for early identification and optimal management of depression to improve health outcomes. Unfortunately, the burden of depression in patients with CVD is under-recognized; as a result, screening and management strategies targeting depression have been poorly implemented in patients with CVD. In this review, we discuss a practical approach for the screening and management of depression in patients with CVD.
No takes yet. Share an insight, caveat, or question.
Jha et al. (2019) conducted a review in Cardiovascular disease and depression. Depression screening and management pathways was evaluated. Standardized screening for depression using validated tools like the PHQ-2 and PHQ-9, followed by multidisciplinary management including SSRIs, cognitive behavioral therapy, or exercise, is recommended for patients with cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: